Mars and Venus: Short- and long-term success of male to female kidney transplantsJuly 30, 2009Proteins on male cells may elicit immune response in female kidney transplant recipients Female recipients of kidneys from deceased male donors demonstrate an increased risk of allograft failure in the first year after transplant, but show no increased risk after ten years, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study authors note that proteins on male donor cells may affect the short term success of kidney transplants in women. Joseph Kim, MD (Toronto General Hospital and the University of Toronto, Canada) and John Gill, MD (St. Paul's Hospital and the University of British Columbia, Canada) studied information on all adult recipients of deceased-donor kidney transplants from 1990 through 2004 in the United States Renal Data System (a system that collects, analyzes, and distributes information about end-stage renal disease in the United States). 117,877 patients were followed for at least one year post transplant. Of these, 16,135 experienced kidney graft failure and 6,878 died within the year. 97,906 patients had functioning grafts at 1-year and were followed for up to 10 years post-transplant. Of these, 35,084 graft failures and 22,566 deaths occurred. The results of this analysis indicate that H-Y antigens, derived from the male chromosome and not found in women, may elicit an immune response in women who receive transplants from deceased male donors. Compared with all other sex combinations, female recipients of male donor kidneys had a 12% increased risk for transplant failure at one year but no excess risk at 10 years. Women who received male donor kidneys also exhibited a similar increased risk of death in the first year, but no increased risk at 10 years. Dr. Kim noted that there are numerous factors that contribute to the success of kidney transplants and that transplanting male kidneys into female recipients often produces excellent outcomes. According to the authors, many important factors should be taken into account when considering transplant options, and "future research should examine the potential mechanisms underlying the H-Y effect in order to better understand the specific role of minor histocompatibility antigens in determining kidney allograft outcomes." American Society of Nephrology |
|||||||||||||||||||||
| Related Kidney Transplants Current Events and Kidney Transplants News Articles Kidney transplants generally safe for lupus patients Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Affordable anti-rejection drug as effective as higher cost option A newer, less expensive drug used to suppress the immune system and prevent organ rejection in kidney and pancreas transplant patients works just as well as its much more expensive counterpart, according to a new study by researchers at Wake Forest University Baptist Medical Center. Strategy for mismatched stem cell transplants triggers protection against graft-vs.-host disease A new technique being tested in stem-cell transplants from imperfectly matched donors has revealed a striking, unforeseen response that can suppress graft-versus-host disease, a common and dangerous complication of mismatched transplants, report scientists from Dana-Farber Cancer Institute. Kidneys from deceased donors with acute renal failure expand donor pool Kidneys recovered from deceased donors with acute renal failure (ARF) - once deemed unusable for transplant - appear to work just as well as kidneys transplanted from deceased donors who do not develop kidney problems prior to organ donation. Rare genetic disease successfully reversed using stem cell transplantation A recent study by Scripps Research Institute scientists offers good news for families of children afflicted with the rare genetic disorder, cystinosis. Cardiac arrest casualties form a valuable source of donor kidneys A pilot study of a system for harvesting kidneys from non-heart-beating donors where attempts of resuscitation after a witnessed out-of-hospital cardiac arrest have failed (uncontrolled NHBDs) resulted in 21 successful kidney transplants - a 10% increase in the transplantation rate - over 17 months. Post-transplant combo can replace toxic immune-suppressing drugs in monkeys Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects. Transplant drug stimulates immune memory Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered. 'Nature vs. nurture' study of deceased donor pairs in kidney transplantation The implications of a new study could improve the outcomes, and potentially survival rates, for some of the thousands of individuals who undergo kidney transplants each year. Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants Screening for mutations in a gene that helps the body metabolize a kidney transplant anti-rejection drug may predict which children are at higher risk for side effects, including compromised white blood cell count or organ rejection, according to new research. More Kidney Transplants Current Events and Kidney Transplants News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||